{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:57:41Z","timestamp":1790225861459,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110110Z\/15\/Z"],"award-info":[{"award-number":["110110Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000275","name":"Leverhulme Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jcv.2020.104548","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T12:01:22Z","timestamp":1594209682000},"page":"104548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8398-0689","authenticated-orcid":false,"given":"Jolynne","family":"Mokaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongai G","family":"Maponga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L","family":"McNaughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-901X","authenticated-orcid":false,"given":"Marije","family":"Van Schalkwyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vattipally B","family":"Sreenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bonsall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"de Cesare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiraaz","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jantje","family":"Taljaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-7910","authenticated-orcid":false,"given":"Wolfgang","family":"Preiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christo","family":"Van Rensburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-4269","authenticated-orcid":false,"given":"Philippa C","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2020.104548_bib0005","series-title":"Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection","author":"World Health Organisation","year":"2019"},{"key":"10.1016\/j.jcv.2020.104548_bib0010","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/liv.14155","article-title":"Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection","author":"Marcellin","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.jcv.2020.104548_bib0015","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3748\/wjg.v24.i17.1919","article-title":"Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-na\u00efve chronic hepatitis B: A case report and review of the literature","volume":"24","author":"Cho","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jcv.2020.104548_bib0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2019.02.006","article-title":"Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients","volume":"70","author":"Park","year":"2019","journal-title":"J. Hepatol."},{"issue":"151","key":"10.1016\/j.jcv.2020.104548_bib0025","article-title":"Hepatitis B virus resistance to tenofovir: fact or fiction? A synthesis of the evidence to date","volume":"5","author":"Mokaya","year":"2020","journal-title":"A systematic literature review and structural analysis of drug resistance mechanisms"},{"key":"10.1016\/j.jcv.2020.104548_bib0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jhep.2014.10.008","article-title":"Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach","volume":"62","author":"Lemoine","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2020.104548_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006629","article-title":"A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: a call for urgent action","volume":"12","author":"Mokaya","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jcv.2020.104548_bib0040","series-title":"Combating Hepatitis B and C to Reach Elimination by 2030","author":"World Health Organisation","year":"2016"},{"key":"10.1016\/j.jcv.2020.104548_bib0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2020.104548_bib0050","series-title":"Global Hepatitis Report","author":"World Health Organisation","year":"2017"},{"key":"10.1016\/j.jcv.2020.104548_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jinf.2020.04.037","article-title":"Treatment advantage in HBV\/HIV coinfection compared to HBV monoinfection in a South African cohort","volume":"81","author":"Maponga","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.jcv.2020.104548_bib0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7196\/SAMJ.6452","article-title":"South African guideline for the management of chronic hepatitis B: 2013","volume":"103","author":"Spearman","year":"2013","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.jcv.2020.104548_bib0065","series-title":"Updated Recommendations on First-line and Second-line Antiretroviral Regimens and Post-exposure Prophylaxis and Recommendations on Early Infant Diagnosis of HIV","author":"World Health Organisation","year":"2019"},{"key":"10.1016\/j.jcv.2020.104548_bib0070","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1038\/s41598-019-43524-9","article-title":"Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)","volume":"9","author":"McNaughton","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcv.2020.104548_bib0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jviromet.2013.07.045","article-title":"Improved rolling circle amplification (RCA) of hepatitis B virus (HBV) relaxed-circular serum DNA (RC-DNA)","volume":"193","author":"Martel","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2020.104548_bib0080","unstructured":"TANOTI: a rapid BLAST-guided read mapper for small, divergent genomes. https:\/\/bioinformatics.cvr.ac.uk\/software\/tanoti\/)."},{"key":"10.1016\/j.jcv.2020.104548_bib0085","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12859-018-2459-9","article-title":"GLUE: a flexible software system for virus sequence data","volume":"19","author":"Singer","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jcv.2020.104548_bib0090","series-title":"Antimicrobial Drug Resistance","article-title":"Hepatitis B virus drug resistance","author":"Beloukas","year":"2017"},{"key":"10.1016\/j.jcv.2020.104548_bib0095","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001387","article-title":"Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences","author":"McNaughton","year":"2020","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jcv.2020.104548_bib0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5009\/gnl18183","article-title":"Treatment outcome and renal safety of 3-year tenofovir disoproxil fumarate therapy in chronic hepatitis B Patients with preserved glomerular filtration rate","volume":"13","author":"Min","year":"2019","journal-title":"Gut Liver"},{"key":"10.1016\/j.jcv.2020.104548_bib0105","first-page":"1","article-title":"Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B","volume":"5","author":"Cui","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcv.2020.104548_bib0110","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1089\/aid.2013.0044","article-title":"Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue","volume":"29","author":"Louissaint","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2020.104548_bib0115","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.30342","article-title":"Highly diverse hepatitis C strains detected in Sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments","volume":"69","author":"Davis","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2020.104548_bib0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep.30225","article-title":"Frequent antiviral treatment failures in patients infected with hepatitis C virus genotype 4, subtype 4r","volume":"69","author":"Fourati","year":"2019","journal-title":"Hepatology"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220302900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220302900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:53:52Z","timestamp":1778810032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653220302900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":24,"alternative-id":["S1386653220302900"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104548","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.03.18.20038216","asserted-by":"object"}]},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104548"}}